MGMT methylation testing in RTOG 0525: A phase III trial of newly diagnosed glioblastoma Article

Aldape, KD, Jones, G, Wang, M et al. (2009). MGMT methylation testing in RTOG 0525: A phase III trial of newly diagnosed glioblastoma . JOURNAL OF CLINICAL ONCOLOGY, 27(15_suppl), 2051-2051. 10.1200/jco.2009.27.15_suppl.2051

cited authors

  • Aldape, KD; Jones, G; Wang, M; Hegi, M; Janzer, RC; Stupp, R; Mehta, MP; Gilbert, MR

authors

publication date

  • May 20, 2009

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 2051

end page

  • 2051

volume

  • 27

issue

  • 15_suppl